Aclaris Therapeutics, Inc. (ACRS) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $7.83M | -58.2% |
| 2024 | $18.72M | -40.1% |
| 2023 | $31.25M | +5.0% |
| 2022 | $29.75M | +340.1% |
| 2021 | $6.76M | +4.3% |
| 2020 | $6.48M | +53.3% |
| 2019 | $4.23M | -31.3% |
| 2018 | $6.15M | +265.5% |
| 2017 | $1.68M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $7.83M | -58.2% |
| 2024 | $18.72M | -40.1% |
| 2023 | $31.25M | +5.0% |
| 2022 | $29.75M | +340.1% |
| 2021 | $6.76M | +4.3% |
| 2020 | $6.48M | +53.3% |
| 2019 | $4.23M | -31.3% |
| 2018 | $6.15M | +265.5% |
| 2017 | $1.68M | — |